Journal article
A case report and focused literature review of d‐penicillamine and severe neutropenia: A serious toxicity from a seldom‐used drug
Clinical Case Reports, Vol.7(5), pp.990-994
04/01/2019
DOI: 10.1002/ccr3.2125
PMCID: PMC6509885
PMID: 31110732
Abstract
Key Clinical Message Prescribing d‐penicillamine for Wilson's disease must be accompanied by vigilant monitoring, including a complete blood cell count with differential. For most, this should occur once or twice weekly during the first month of therapy and during periods of dose escalation, then every two weeks for six additional months, then monthly.
Details
- Title: Subtitle
- A case report and focused literature review of d‐penicillamine and severe neutropenia: A serious toxicity from a seldom‐used drug
- Creators
- Stuart K Pitman - University of Iowa, Pharmacy Practice and ScienceTony Huynh - University of Iowa, University of Iowa Health CareThorarinn A Bjarnason - University of IowaJosiah An - University of IowaKaren A Malkhasyan - Yale University
- Resource Type
- Journal article
- Publication Details
- Clinical Case Reports, Vol.7(5), pp.990-994
- DOI
- 10.1002/ccr3.2125
- PMID
- 31110732
- PMCID
- PMC6509885
- NLM abbreviation
- Clin Case Rep
- eISSN
- 2050-0904
- Publisher
- John Wiley and Sons Inc
- Copyright
- © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
- Language
- English
- Date published
- 04/01/2019
- Academic Unit
- Pharmacy Practice and Science; Applied Clinical Sciences
- Record Identifier
- 9983735380302771
Metrics
86 File views/ downloads
102 Record Views